Cingulate Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Cingulate Inc. now
Current reporting with the operating signal separated from the noise.
CINGW Cingulate Inc. WT EXP 121026
The story matters when it changes Cingulate Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Reportable, Inc.: Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25
The story matters when it changes Cingulate Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301
The story matters when it changes Cingulate Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Stonegate, Inc.: Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
The story matters when it changes Cingulate Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
The story matters when it changes Cingulate Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
The story matters when it changes Cingulate Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Cingulate Inc. Secures $5 Million Financing to Support Pharmaceutical Development Initiatives
The story matters when it changes Cingulate Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest CING filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Cingulate Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →